Search

everythinglearnresearchcommunity

for

Search:↓

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Taking L-tryptophan supplements might cause a condition similar to scleroderma in some people, which can get better after stopping the supplement and starting corticosteroid therapy.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

Hair loss can be an early sign of HIV infection.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

COVID-19 may cause hair loss and scalp pain due to inflammation and changes in hair follicle receptors, but these symptoms typically resolve in 2 to 4 months.

Cynatine HNS improves hair and nail quality in 90 days.

Good nutrition is crucial for healthy hair and can help with hair loss without medication.

The study found that polymorphous light eruption varies among patients and can be distinguished from benign summer light eruption by the time it takes for symptoms to appear after sun exposure.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

Many people with hair loss had low iron and ferritin levels.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Caffeine may help reduce stress-induced hair loss.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.

COVID-19 may trigger sudden temporary hair loss.

Trichoscopy is useful for diagnosing hair and scalp disorders in people with darker skin.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.